Wednesday, August 03, 2005

Govt. bans Valdecoxib in India

The central government has banned the block-buster arthritis drug, Valdecoxib. The generic versions of this drug, invented by one the leading brands in life saving drugs segment Pfizer, is currently manufactured and marketed in India by Cipla, Ranbaxy, Dr Reddy's Lab, Nicholas Piramal, Glenmark and seven other pharmaceutical companies. The total market for this drug is estimated to be Rs 90 crore approximately. The ban follows the National Pharmacovigilance Advisory Committee (NPAC) recommendation that the drug may be prohibited for manufacture and sale in India under the Drugs and Cosmetics Act, 1950. Studies abroad have shown that the prolonged use of the drug may have the risk of heart attacks apart from serious skin reactions.